首页> 外文期刊>Pharmacology & Pharmacy >The Quality and in Vitro Efficacy of Amoxicillin/Clavulanic Acid Formulations in the Central Region of Ghana
【24h】

The Quality and in Vitro Efficacy of Amoxicillin/Clavulanic Acid Formulations in the Central Region of Ghana

机译:加纳中部地区阿莫西林/克拉维酸制剂的质量和体外功效

获取原文
           

摘要

Aim: To assess the quality and in vitro efficacy of five brands of amoxicillin/clavulanic acid tablet, suspension and injectable preparations selected from pharmacies in the Central Region of Ghana. Method: Using a Stratified Representation Sampling method, forty preparations (tablets, suspensions and injectable powders) containing amoxicillin and clavulanic acid were sampled from nine different locations within the Central Region of Ghana. To determine drug quality, several procedures, namely, content assay, disintegration and dissolution testing were employed. In vitro drug efficacy was determined by comparing the Minimum Inhibitory Concentrations (MIC’s) obtained with published values. Results: All tablets passed the disintegration test, with disintegration time ranging between six (6) and fifteen (15) minutes. Analyses of all the tablets for drug content showed 100% failure (14 out of 14) for amoxicillin and 14% failure (2 out of 14) for clavulanic acid. Injectable formulations showed similar results. All four (4) samples analyzed for content failed the amoxicillin content assay (0 out of 4) but all passed clavulanic acid assay (4 out of 4). For tablet dissolution tests, there was a 93% (13 out of 14) pass rate for both amoxicillin and clavulanic acid. Content analysis of all suspension formulations involved twenty-two (22) samples from five (5) brands. Only 41% (9 out of 22) passed for both amoxicillin and clavulanic acid. All the other samples failed for either amoxicillin, clavulanic acid or both. Results obtained from drug quality tests were confirmed by in vitro efficacy tests against selected microorganisms. Conclusion: The samples were therefore not of good quality, since content assay is the most crucial test. It is hypothesized that this is due to poor storage conditions, and recommendations, such as air conditioning and more structured procedures along the supply chain, are put forward to counteract this.
机译:目的:评估选自加纳中部地区药房的五个品牌的阿莫西林/克拉维酸片剂,混悬剂和注射剂的质量和体外功效。方法:使用分层表示采样方法,从加纳中部地区的九个不同地点采样了四十种含有阿莫西林和克拉维酸的制剂(片剂,混悬剂和可注射粉剂)。为了确定药物质量,采用了几种程序,即含量测定,崩解和溶出度测试。通过将获得的最低抑菌浓度(MIC)与公开值进行比较来确定体外药物疗效。结果:所有片剂均通过崩解测试,崩解时间介于六(6)到十五(15)分钟之间。所有片剂的药物含量分析均显示,阿莫西林失败率100%(14个中的14个),克拉维酸失败率14%(14个中的2个)。注射剂显示出相似的结果。分析的所有四(4)个样品的含量均未通过阿莫西林含量测定(4个中的0个),但均通过了克拉维酸测定(4个中的4个)。对于片剂溶出度测试,阿莫西林和克拉维酸的通过率均为93%(14个中的13个)。所有悬浮液配方的含量分析涉及五(5)个品牌的二十二(22)个样品。阿莫西林和克拉维酸均仅通过了41%(22个中的9个)。所有其他样品的阿莫西林,克拉维酸或两者均未通过。从药物质量测试获得的结果通过针对所选微生物的体外功效测试得到证实。结论:由于含量测定是最关键的测试,因此样品质量不佳。据推测,这是由于不良的存储条件造成的,并提出了应对措施,例如空调和整个供应链中结构化的程序等建议。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号